Appropriately testing patients with intermediate risk for coronary artery disease: how well are we doing?

Ali A Alsaad1,2, Brian P Shapiro1,3

  • 1Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA.

Insights

Clinicians can reduce unnecessary myocardial perfusion imaging by using appropriate use criteria. A simple step-by-step guide is proposed to aid primary care physicians in risk stratification for coronary artery disease before ordering tests.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Evidence-Based Medicine

Background:

  • Effective cardiovascular risk assessment is crucial for managing stable coronary artery disease.
  • Risk stratification tools help identify patients at intermediate to high risk for coronary events.
  • These identified patients often require further non-invasive or invasive cardiovascular testing.

Purpose of the Study:

  • To review evidence on risk stratification tools and non-invasive testing for intermediate-risk coronary artery disease patients.
  • To propose a straightforward method for clinicians before ordering non-invasive cardiovascular tests.
  • To address the issue of overtesting in myocardial perfusion imaging.

Main Methods:

  • Literature review of PubMed and MEDLINE Central.
  • Focus on studies and evidence concerning appropriate use criteria for radionuclide myocardial perfusion imaging.
  • Synthesis of evidence to inform clinical decision-making.

Main Results:

  • Overutilization of myocardial perfusion imaging is a documented issue in medical literature.
  • Appropriate use criteria can significantly decrease unnecessary testing for suspected coronary artery disease.
  • A 'Simple Steps to Follow' guide is proposed for clinicians.

Conclusions:

  • Adherence to appropriate use criteria for radionuclide myocardial perfusion imaging is essential.
  • The proposed 'Simple Steps to Follow' can help prevent overtesting.
  • The guide targets primary care physicians and non-cardiologist specialists.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
516
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
733
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
391